LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Lyra Therapeutics (NASDAQ: LYRA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ LYRA Lyra Therapeutics
Palasis Maria / director, officer: President & CEO
10/01/2025
Buy
$303.50
3,667
$1.113M
7,333